These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14978088)

  • 1. In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin.
    Goodyear CS; Narita M; Silverman GJ
    J Immunol; 2004 Mar; 172(5):2870-7. PubMed ID: 14978088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo VL-targeted microbial superantigen induced global shifts in the B cell repertoire.
    Grönwall C; Kosakovsky Pond SL; Young JA; Silverman GJ
    J Immunol; 2012 Jul; 189(2):850-9. PubMed ID: 22696444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin.
    Goodyear CS; Silverman GJ
    J Exp Med; 2003 May; 197(9):1125-39. PubMed ID: 12719481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells.
    Snyder CM; Zhang X; Wysocki LJ
    J Immunol; 2002 Apr; 168(8):3865-73. PubMed ID: 11937540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.
    Corcos D; Grandien A; Vazquez A; Dunda O; Lorès P; Bucchini D
    J Immunol; 2001 Mar; 166(5):3083-9. PubMed ID: 11207259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L.
    Viau M; Longo NS; Lipsky PE; Björck L; Zouali M
    Infect Immun; 2004 Jun; 72(6):3515-23. PubMed ID: 15155659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body autoradiography reveals that the Peptostreptococcus magnus immunoglobulin-binding domains of protein L preferentially target B lymphocytes in the spleen and lymph nodes in vivo.
    Smith D; D'Argy R; Nilsson M; Yrlid U; de Jersey J; Björck L; Wick MJ
    Cell Microbiol; 2004 Jul; 6(7):609-23. PubMed ID: 15186398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal and dose-dependent relationships between in vivo B cell receptor-targeted proliferation and deletion-induced by a microbial B cell toxin.
    Goodyear CS; Sugiyama F; Silverman GJ
    J Immunol; 2006 Feb; 176(4):2262-71. PubMed ID: 16455982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of superantigen-induced clonal deletion with a novel clan III-restricted avian monoclonal antibody: exploiting evolutionary distance to create antibodies specific for a conserved VH region surface.
    Cary SP; Lee J; Wagenknecht R; Silverman GJ
    J Immunol; 2000 May; 164(9):4730-41. PubMed ID: 10779779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple germline kappa light chains generate anti-insulin B cells in nonobese diabetic mice.
    Woodward EJ; Thomas JW
    J Immunol; 2005 Jul; 175(2):1073-9. PubMed ID: 16002708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A VH11V kappa 9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro.
    Chumley MJ; Dal Porto JM; Kawaguchi S; Cambier JC; Nemazee D; Hardy RR
    J Immunol; 2000 May; 164(9):4586-93. PubMed ID: 10779761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing.
    Ota T; Ota M; Duong BH; Gavin AL; Nemazee D
    J Exp Med; 2011 Mar; 208(3):617-29. PubMed ID: 21357741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation.
    Widhopf GF; Brinson DC; Kipps TJ; Tighe H
    J Immunol; 2004 Feb; 172(4):2092-9. PubMed ID: 14764674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of a superantigen-induced hole in the repertoire of natural IgM-secreting cells.
    Silverman GJ
    Cell Immunol; 2001 Apr; 209(1):76-80. PubMed ID: 11414738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A B-Cell Superantigen Induces the Apoptosis of Murine and Human Malignant B Cells.
    Lorenzo D; Duarte A; Mundiñano J; Berguer P; Nepomnaschy I; Piazzon I
    PLoS One; 2016; 11(9):e0162456. PubMed ID: 27603942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin V binds to positively selected B cells.
    Dillon SR; Constantinescu A; Schlissel MS
    J Immunol; 2001 Jan; 166(1):58-71. PubMed ID: 11123277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.